Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helga Nagy

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Ideggyogyaszati Szemle|April 9, 2019
[Rehabilitation possibilities and results after neurosurgical intervention of brain tumors]Zoltán Dénes, Szilvia Tarjányi, Helga Nagy
Neuro-Degenerative Diseases|October 6, 2012
Delay discounting of reward and caudate nucleus volume in individuals with α-synuclein gene duplication before and after the development of Parkinson's diseaseAndrás Szamosi, Helga Nagy, Szabolcs Kéri
Ideggyogyaszati Szemle|February 22, 2018
Insights into the structure and function of the hippocampal formation: Relevance to Parkinson's diseaseOrsolya Györfi, Helga Nagy, Magdolna Bokor, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|July 9, 2016
Behavioural aspects of a modified crosstalk between basal ganglia and limbic system in Parkinson's diseaseOrsolya Gyorfi, Helga Nagy, Magdolna Bokor, et al.
The European Journal of Neuroscience|September 10, 2013
How attentional boost interacts with reward: the effect of dopaminergic medications in Parkinson's diseaseSzabolcs Kéri, Helga Nagy, Einat Levy-Gigi, et al.
Ideggyogyaszati Szemle|February 22, 2014
[Treatment possibilities in advanced Parkinson's disease]Annamária Takáts, Helga Nagy, Péter Radics, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 9, 2016
A single dose of L-DOPA changes perceptual experiences and decreases latent inhibition in Parkinson's diseaseOrsolya Györfi, Helga Nagy, Magdolna Bokor, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|January 5, 2016
[Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease]Adrián Toth, Helga Nagy, Judit Wacha, et al.
Ideggyogyaszati Szemle|November 9, 2007
Possible role of the basal ganglia in the generation of the N30 potential of the median nerve somatosensory evoked potentialsSándor Beniczky, Helga Nagy, Edina Varga, et al.
Neuroscience Letters|January 29, 2016
Dopamine improves exploration after expectancy violations and induces psychotic-like experiences in patients with Parkinson's diseaseBertalan Polner, Ahmed A Moustafa, Helga Nagy, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Ideggyogyaszati Szemle|April 9, 2019
[Rehabilitation possibilities and results after neurosurgical intervention of brain tumors]Zoltán Dénes, Szilvia Tarjányi, Helga Nagy
Neuro-Degenerative Diseases|October 6, 2012
Delay discounting of reward and caudate nucleus volume in individuals with α-synuclein gene duplication before and after the development of Parkinson's diseaseAndrás Szamosi, Helga Nagy, Szabolcs Kéri
Ideggyogyaszati Szemle|February 22, 2018
Insights into the structure and function of the hippocampal formation: Relevance to Parkinson's diseaseOrsolya Györfi, Helga Nagy, Magdolna Bokor, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|July 9, 2016
Behavioural aspects of a modified crosstalk between basal ganglia and limbic system in Parkinson's diseaseOrsolya Gyorfi, Helga Nagy, Magdolna Bokor, et al.
The European Journal of Neuroscience|September 10, 2013
How attentional boost interacts with reward: the effect of dopaminergic medications in Parkinson's diseaseSzabolcs Kéri, Helga Nagy, Einat Levy-Gigi, et al.
Ideggyogyaszati Szemle|February 22, 2014
[Treatment possibilities in advanced Parkinson's disease]Annamária Takáts, Helga Nagy, Péter Radics, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 9, 2016
A single dose of L-DOPA changes perceptual experiences and decreases latent inhibition in Parkinson's diseaseOrsolya Györfi, Helga Nagy, Magdolna Bokor, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|January 5, 2016
[Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease]Adrián Toth, Helga Nagy, Judit Wacha, et al.
Ideggyogyaszati Szemle|November 9, 2007
Possible role of the basal ganglia in the generation of the N30 potential of the median nerve somatosensory evoked potentialsSándor Beniczky, Helga Nagy, Edina Varga, et al.
Neuroscience Letters|January 29, 2016
Dopamine improves exploration after expectancy violations and induces psychotic-like experiences in patients with Parkinson's diseaseBertalan Polner, Ahmed A Moustafa, Helga Nagy, et al.
Pageof 3